Huma Qamar
CIK 2015296 · View on SEC EDGAR ↗
First SEC filing: March 20, 2024 · Latest: March 20, 2024
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2025 | OCGN | A | 1,145,468 | — | — | 1,145,468 Direct | — | Acquired | (price as of 2026-08-18) |
| April 16, 2024 | OCGN | A | 308,465 | — | — | 308,465 Direct | — | Acquired | (price as of 2026-08-18) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 2, 2025 | OCGN | Option (Right to Buy) | Common Stock (1,145,468) | $0.90 | Jan. 2, 2035 | 1,145,468 | Acquired |
| April 16, 2024 | OCGN | Option (Right to Buy) | Common Stock (308,465) | $1.59 | April 16, 2034 | 308,465 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| March 20, 2024 | OCGN | Common Stock | 1,643 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
OCGN
M.D., MPH, CMI (7) Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $448,050 | $190,130 | $1,375,478 | $868,975 | — | — | $5,847 | $2,888,481 |
| 2024 | $344,375 | $258,362 | $709,003 | $413,961 | — | — | — | $1,725,700 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.